Description: IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. In addition, the company focuses in therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, and orphan and rare diseases. Further, the company engages in the data collection and analysis of neurological disorders. Additionally, it offers drug development analytics, imaging operation, post marketing surveillance, and consultancy services; and end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.
Home Page: ixico.com
Griffin Court
London,
EC1A 9PN
United Kingdom
Phone:
44 20 3763 7499
Officers
| Name | Title |
|---|---|
| Mr. Grant Nash | CFO, Company Secretary & Executive Director |
| Mr. Bram Goorden M.Sc. | Chief Executive Officer |
| Prof. Daniel Rueckert | Co-Founder & Member of Scientific Advisory Board |
| Prof. Derek Lionel Glendon Hill | Co-Founder and President of Regulatory Science & External Relations |
| Prof. David Hawkes CPhys, FInstP, FIPEM, FREng, Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Prof. Joseph Hajnal | Co-Founder & Member of Scientific Advisory Board |
| Mr. Mark Austin | Director of Technology |
| Dr. Robin Wolz | Chief Scientific Officer |
| Ms. Hannah Esfahanian | HR Manager |
| Dr. John Hall | Senior Vice President of Business Development |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0074 |
| Price-to-Sales TTM: | 2.0059 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 89 |